How major risk factors relate to hospitalization or mortality.
CDMO Serán sets out to build first commercial facility, with a $200M investment led by Bain Capital
Small molecule contract manufacturer Serán Bioscience is building its first commercial-scale manufacturing facility, backed by a $200 million investment from Bain Capital and others. …